Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 3 , Pages 290-293 , May 2012

Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer

  • Michael Staehler, M.D.

      Affiliations

    • Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-89-7095-3722; fax: +49-89-7095-6722
  • ,
  • Nicolas Haseke, M.D.

      Affiliations

    • Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany
  • ,
  • Thomas Stadler, M.D.

      Affiliations

    • Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany
  • ,
  • Philipp Nuhn, M.D.

      Affiliations

    • Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany
  • ,
  • Alexander Roosen, M.D.

      Affiliations

    • Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany
  • ,
  • Christian G. Stief, M.D.

      Affiliations

    • Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany
  • ,
  • Ralf Wilkowski, M.D.

      Affiliations

    • Department of Radiotherapy, Klinik Bad Trissl, Oberaudorf, Germany

Received 19 November 2009 ,Revised 6 February 2010 ,Accepted 10 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(10)00047-5

doi: 10.1016/j.urolonc.2010.02.006

Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 3 , Pages 290-293 , May 2012